← Leaderboards
Xiang-Yang Wang
Roswell Park Cancer Institute Corp
$11,998,946
Attributed
$18,389,607
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,389,607 · 13
VA$0 · 1
By mechanism
R01$16,883,563 · 10
P01$907,240 · 1
R21$355,316 · 1
P30$243,488 · 1
I01$0 · 1
Top collaborators
- Xianjun Fang5 shared
- Paul B Fisher5 shared
- Devanand Sarkar5 shared
- Elizabeth Repasky4 shared
- Shijun Zhang4 shared
- John R. Subjeck3 shared
- Dong Sun3 shared
- Guizhi Zhu2 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- John R. Subjeck$12,071,773
- Elizabeth Repasky$12,725,917
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneMolecularSignal TransductionTumorResponseT-LymphocyteImmune ResponseInnovationMediatingAntigensBaseMalignant NeoplasmsImmunityClinicInflammatoryMouse ModelImmunotherapyCellsImmunologicsVaccinesClinically RelevantImmunotherapeutic AgentPhenotypeProduction
Grant awards (55)
Multivalent Small Circular mRNA Vaccines for Melanoma Combination Immunotherapy$563,293
R01 · FY2025 · CA
Interplay between tumor and microenvironment in bone metastasis$470,956
R01 · FY2025 · CA
A Novel Target in The Tumor Myeloid Compartment for Hepatocellular Carcinoma$453,620
P01 · FY2025 · CA · contact PI
Exploiting immunostimulatory microbial pattern recognition to improve head and neck cancer therapy$427,208
R01 · FY2025 · DE · contact PI
Developmental Therapeutics Research Program$243,488
P30 · FY2025 · CA · contact PI
Fatty Acid Oxidation in Regulation of Drug Hepatotoxicity$0
I01 · FY2025 · VA · contact PI
Multivalent Small Circular mRNA Vaccines for Melanoma Combination Immunotherapy$577,293
R01 · FY2024 · CA
A Novel Target in The Tumor Myeloid Compartment for Hepatocellular Carcinoma$453,620
P01 · FY2024 · CA · contact PI
Interplay between tumor and microenvironment in bone metastasis$447,407
R01 · FY2024 · CA
A novel role of IGFBP7 in the microenvironment of hepatocellular carcinoma$476,580
R01 · FY2023 · CA
Interplay between tumor and microenvironment in bone metastasis$461,537
R01 · FY2023 · CA
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy$404,924
R01 · FY2023 · CA · contact PI
Innate Pattern Recognition Receptor and Acetaminophen-induced Liver Injury$0
I01 · FY2023 · VA · contact PI
A novel role of IGFBP7 in the microenvironment of hepatocellular carcinoma$476,580
R01 · FY2022 · CA
Interplay between tumor and microenvironment in bone metastasis$461,537
R01 · FY2022 · CA
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy$406,274
R01 · FY2022 · CA · contact PI
Innate Pattern Recognition Receptor and Acetaminophen-induced Liver Injury$0
I01 · FY2022 · VA · contact PI
A novel role of IGFBP7 in the microenvironment of hepatocellular carcinoma$486,305
R01 · FY2021 · CA
Interplay between tumor and microenvironment in bone metastasis$470,956
R01 · FY2021 · CA
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy$410,049
R01 · FY2021 · CA · contact PI
Innate Pattern Recognition Receptor and Acetaminophen-induced Liver Injury$0
I01 · FY2021 · VA · contact PI
Development of NLRP3 inflammasome inhibitors towards Alzheimer's disease$610,312
R01 · FY2020 · AG
A novel role of IGFBP7 in the microenvironment of hepatocellular carcinoma$486,305
R01 · FY2020 · CA
Development of NLRP3 inflammasome inhibitors towards Alzheimer's disease$462,952
R01 · FY2020 · AG
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy$413,046
R01 · FY2020 · CA · contact PI
Large heat shock proteins and their role in cancer therapy$326,813
R01 · FY2020 · CA
Innate Pattern Recognition Receptor and Acetaminophen-induced Liver Injury$0
I01 · FY2020 · VA · contact PI
Development of NLRP3 inflammasome inhibitors towards Alzheimer's disease$609,829
R01 · FY2019 · AG
A novel role of IGFBP7 in the microenvironment of hepatocellular carcinoma$500,003
R01 · FY2019 · CA
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy$412,390
R01 · FY2019 · CA · contact PI
Large heat shock proteins and their role in cancer therapy$317,333
R01 · FY2019 · CA
Large heat shock proteins and their role in cancer therapy$155,000
R01 · FY2019 · CA
Innate Pattern Recognition Receptor and Acetaminophen-induced Liver Injury$0
I01 · FY2019 · VA · contact PI
Development of NLRP3 inflammasome inhibitors towards Alzheimer's disease$609,347
R01 · FY2018 · AG
Large heat shock proteins and their role in cancer therapy$327,475
R01 · FY2018 · CA
Host-tumor interactions and cancer relapse after radiation therapy$316,438
R01 · FY2018 · CA · contact PI
Large heat shock proteins and their role in cancer therapy$327,797
R01 · FY2017 · CA
Host-tumor interactions and cancer relapse after radiation therapy$316,438
R01 · FY2017 · CA · contact PI
Large heat shock proteins and their role in cancer therapy$155,000
R01 · FY2017 · CA
Large heat shock proteins and their role in cancer therapy$344,200
R01 · FY2016 · CA
Host-tumor interactions and cancer relapse after radiation therapy$316,438
R01 · FY2016 · CA · contact PI
Host-tumor interactions and cancer relapse after radiation therapy$316,438
R01 · FY2015 · CA · contact PI
Large Stress Proteins in Biology and Medicine$310,213
R01 · FY2015 · CA · contact PI
Host-tumor interactions and cancer relapse after radiation therapy$316,438
R01 · FY2014 · CA · contact PI
Large Stress Proteins in Biology and Medicine$300,907
R01 · FY2014 · CA · contact PI
Large Stress Proteins in Biology and Medicine$291,600
R01 · FY2013 · CA · contact PI
Large Stress Proteins in Biology and Medicine$310,213
R01 · FY2012 · CA · contact PI
Large Stress Proteins in Biology and Medicine$310,213
R01 · FY2011 · CA · contact PI
Scavenger Receptor-A and Immune Regulation$220,423
R01 · FY2011 · CA · contact PI
Scavenger Receptor-A and Immune Regulation$227,240
R01 · FY2010 · CA · contact PI
Scavenger Receptor-A and Immune Regulation$227,240
R01 · FY2009 · CA · contact PI
Scavenger Receptor-A and Immune Regulation$253,794
R01 · FY2008 · CA · contact PI
Scavenger Receptor-A and Immune Regulation$250,829
R01 · FY2007 · CA · contact PI
Immunochaperone-based gene therapy targeting prostate cancer$185,510
R21 · FY2007 · CA · contact PI
Immunochaperone-based gene therapy targeting prostate cancer$169,806
R21 · FY2006 · CA · contact PI